Physician profile
Sarmela T Sunder
NPI 1417053760
$85,000.62
in general payments reported to CMS, 2019-2025
8 companies · $15K in 2025
The $15K reported for 2025 was more than what 97% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $19K · 2021: $21K · 2022: $474 · 2023: $479 · 2024: $3,556 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $1,800 · Travel and Lodging: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,650.00 |
| Food and Beverage | $1,799.80 |
| Travel and Lodging | $492.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $58,760.05 | 2019-2022 | |
| Abbvie INC. | $17,853.46 | 2022-2025 | |
| Galderma Laboratories, L.P. | $7,846.26 | 2019-2025 | |
| Revance Therapeutics, INC. | $416.95 | 2024 | Daxxify |
| Merz North America, INC. | $41.66 | 2019-2020 | |
| Stryker Corporation | $33.08 | 2025 | Sonopet Iq |
| Endo Pharmaceuticals INC. | $32.58 | 2019 | |
| Tela Bio, INC. | $16.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarmela Sunder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.